Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

9.16 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Omzet 73.464.17974.14166.86568.91479.025204.713191.263242.732244.293228.444204.81217.775148.21198.35387.85946.90550.98135.96
Kosten van de omzet 45.1445.20435.70836.68643.27333.67653.25338.17637.49640.03239.13832.04737.51330.36823.39519.7621.19715.29717.83
Brutowinst 28.2618.97538.43330.17925.64145.349151.46153.087205.236204.261189.306172.763180.262117.84374.95868.09925.70835.68418.13
Brutowinstmarge 0.3850.2960.5180.4510.3720.5740.740.80.8460.8360.8290.8440.8280.7950.7620.7750.5480.70.504
Onderzoek- en ontwikkelingskosten 5.2845.0324.5944.3474.1944.1455.0115.3894.2743.6959.1841.951.9322.1642.0921.8681.63.7440.979
Algemene en administratieve kosten 00000000000000000015.784
Verkoop- en marketingkosten 0000000000000000000
Verkoop-, algemene en administratieve kosten 34.78931.19733.62638.86435.37738.67137.20330.79528.06133.225.58125.18924.08523.23741.62120.5115.98816.12615.784
Overige kosten -2.5620.1060.0490.066-1.620.1680.914-0.004-1.2750.0070.2010.078-0.0030.003-7.5980.0320.020.080.023
Bedrijfskosten 40.07336.22938.2243.21139.57142.81642.21436.18432.33536.89534.76527.13926.01725.40143.71322.37817.58819.8716.763
Bedrijfsresultaat -11.813-17.2540.213-15.417-11.614-2.161109.246116.903180.701167.366154.541156.873154.24592.44231.24545.7218.1234.8161.286
Bedrijfsresultaat ratio -0.161-0.2690.003-0.231-0.169-0.0270.5340.6110.7440.6850.6760.7660.7080.6240.3180.520.1730.6830.036
Totaal overige inkomsten en kosten netto -5.114-5.155655.973-3.3260.797-2.362-13.37-3.14-5.709-0.525-2.8314.573-0.0035.889-7.5980.0320.0219.082-0.058
Inkomen voor belasting -16.927-22.409656.186-20.563-13.364-4.52395.876113.763174.992166.841144.689151.652145.7389.56114.84138.6640.67727.514-6.41
Inkomen voor belasting ratio -0.231-0.3498.851-0.308-0.194-0.0570.4680.5950.7210.6830.6330.740.6690.6040.1510.440.0140.54-0.178
Belastingkosten -2.4350.271766.168-5.461-1.421-3.1758.44714.1118.27119.98117.57818.84211.38613.7090.369-0.359-0.7653.635-0.96
Nettowinst -7.585-12.078-105.959-6.462-6.541-1.34887.42999.653156.721146.8655.8354.27449.07523.24725.20938.950.20723.389-5.391
Nettowinstmarge -0.103-0.188-1.429-0.097-0.095-0.0170.4270.5210.6460.6010.2440.2650.2250.1570.2560.4430.0040.459-0.15
WPA (Winst Per Aandeel) -0.056-0.091-0.8-0.049-0.05-0.010.660.760.610.580.420.460.440.240.60.440.0020.26-0.056
Verwaterde WPA -0.056-0.091-0.8-0.049-0.05-0.010.660.760.610.580.420.440.440.240.130.440.0020.26-0.056
EBITDA 2.734-3.50113.193-5.534-8.7598.746112.498116.899171.626174.755154.742145.702154.24292.44523.64752.42414.61522.668.025
EBITDA ratio 0.037-0.0550.178-0.083-0.1270.1110.550.6110.7070.7150.6770.7110.7080.6240.240.5970.3120.4440.223